| P50 | author | Ahmed Hussein | Q56754276 |
| | Yehia Mechref | Q38800719 |
| P2093 | author name string | Yunli Hu | |
| | Aldo Garcia | |
| P2860 | cites work | Cancer statistics, 2010 | Q27860525 |
| | Roles for glycosylation of cell surface receptors involved in cellular immune recognition | Q28146004 |
| | Mannose receptor-mediated regulation of serum glycoprotein homeostasis | Q28205913 |
| | Biological roles of oligosaccharides: all of the theories are correct | Q29616459 |
| | Intracellular functions of N-linked glycans | Q29617165 |
| | Pancreatic cancer | Q29622871 |
| | Derivatization for stabilizing sialic acids in MALDI-MS. | Q30858390 |
| | A high-performance liquid chromatography based strategy for rapid, sensitive sequencing of N-linked oligosaccharide modifications to proteins in sodium dodecyl sulphate polyacrylamide electrophoresis gel bands | Q31027284 |
| | Solid-phase permethylation of glycans for mass spectrometric analysis | Q33226041 |
| | Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. | Q33237312 |
| | Miniaturized separation techniques in glycomic investigations | Q33247136 |
| | Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer | Q33249056 |
| | A serum glycomics approach to breast cancer biomarkers | Q33250468 |
| | Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study | Q33269243 |
| | Alterations in the serum glycome due to metastatic prostate cancer | Q33282042 |
| | High-throughput solid-phase permethylation of glycans prior to mass spectrometry | Q33319234 |
| | Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles | Q33335630 |
| | Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines | Q33397989 |
| | Detection of hepatocellular carcinoma using glycomic analysis | Q33410061 |
| | Glycoproteomics and glycomics investigation of membrane N-glycosylproteins from human colon carcinoma cells | Q46465336 |
| | Separation of N-glycans by HPLC. | Q46676858 |
| | Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. | Q46989470 |
| | Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? | Q47289278 |
| | Expression of -galactoside 2,6 sialyltransferase and of 2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis | Q47599675 |
| | A retrospective and prospective view of glycopathology | Q48011635 |
| | Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts | Q60678398 |
| | Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values | Q71624424 |
| | Estimating future hepatitis C morbidity, mortality, and costs in the United States | Q73073538 |
| | Enhanced expression of alpha 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma | Q73507169 |
| | Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer | Q77343384 |
| | Glycobiology: Toward Understanding the Function of Sugars | Q77646225 |
| | Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum | Q79847197 |
| | Glycomic profiling of invasive and non-invasive breast cancer cells | Q81886862 |
| | Technologies and strategies for glycoproteomics and glycomics and their application to clinical biomarker research | Q99556097 |
| | Solid-phase permethylation for glycomic analysis | Q33416886 |
| | Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins | Q33546544 |
| | Protein glycosylation in development and disease | Q33665058 |
| | N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin | Q33732475 |
| | Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer | Q33850105 |
| | Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery. | Q34022368 |
| | Estimates of cancer incidence and mortality in Europe in 2008. | Q34095813 |
| | Prostate-specific antigen: current status | Q34151987 |
| | Structural investigations of glycoconjugates at high sensitivity | Q34527398 |
| | Serum tumor markers in the management of ovarian, endometrial and cervical cancer | Q34544727 |
| | Early detection of pancreatic carcinoma | Q34684186 |
| | A genetic approach to Mammalian glycan function | Q35099563 |
| | N-glycosylation of serum proteins in disease and its investigation using lectins | Q35678410 |
| | Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis | Q35803550 |
| | Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets | Q35892699 |
| | Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers | Q35902976 |
| | Analysis of glycans derived from glycoconjugates by capillary electrophoresis-mass spectrometry. | Q35988418 |
| | Serum tumor markers in breast cancer: are they of clinical value? | Q36367261 |
| | Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS | Q37055406 |
| | Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation | Q37223561 |
| | Mass spectrometry and the emerging field of glycomics | Q37274089 |
| | Glycomics and disease markers | Q37457130 |
| | Application of nano-LC-based glycomics towards biomarker discovery | Q37961971 |
| | Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells | Q38289793 |
| | The effects of variable glycosylation on the functional activities of ribonuclease, plasminogen and tissue plasminogen activator. | Q38296838 |
| | N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis | Q38305466 |
| | Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins | Q39958987 |
| | Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism | Q41270282 |
| | Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. | Q43004363 |
| | Cancer statistics, 2003. | Q43729872 |
| | Changing patterns in the incidence of esophageal and gastric carcinoma in the United States | Q43873434 |
| | Elimination of oxidative degradation during the per-O-methylation of carbohydrates | Q44704240 |
| | Prostate-specific Antigen: Its Usefulness in Clinical Medicine | Q45876737 |
| | Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals | Q46218056 |
| | A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression | Q46345968 |
| P4510 | describes a project that uses | mass spectrometry | Q180809 |
| P433 | issue | 12 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 1755-1767 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Electrophoresis | Q3050608 |
| P1476 | title | Identifying cancer biomarkers by mass spectrometry-based glycomics | |
| P478 | volume | 33 | |